TrialRadiation oncology (London, England)2012

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy.

Jeffrey Vainshtein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.